The graduate program in Pharmaceutical Economics and Policy (PEP) offers a Doctor of Philosophy (PhD) in Pharmaceutical Health Economics and Policy with specialty tracks or concentrations in Health and Pharmacoepidemiology and Health Economics and Outcomes Research. This graduate program offers academic training primarily in the areas of pharmaceutical and health economics and drug and health policy, and also provides related training in outcomes research, regulation, marketing, healthcare administration, pharmacy services research, and pharmacoepidemiology.

The curriculum features advanced didactic and experiential education in the areas of pharmacoeconomic and health policy analysis, pharmacoepidemiologic methods and study designs, advanced biostatistics and database management, health policy and behavioral interventions and their assessment, and the role of pharmaceuticals and medical devices in healthcare and society. The program provides future leaders, educators, and researchers with the knowledge required to enhance access for patient populations to cost-effective pharmaceuticals, biologics, medical devices, and related health services, thus improving the efficiency of the pharmaceutical sector and healthcare systems. Graduates will be prepared for careers in the pharmaceutical, biotechnology, and medical device industries; hospitals and other institutional healthcare organizations; managed care organizations; pharmacy benefits management; contract research organizations; consulting firms; governments; international organizations; nongovernmental organizations; and academic institutions, among other organizations.